454 related articles for article (PubMed ID: 17407101)
1. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis.
Piccio L; Buonsanti C; Mariani M; Cella M; Gilfillan S; Cross AH; Colonna M; Panina-Bordignon P
Eur J Immunol; 2007 May; 37(5):1290-301. PubMed ID: 17407101
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.
Maresz K; Carrier EJ; Ponomarev ED; Hillard CJ; Dittel BN
J Neurochem; 2005 Oct; 95(2):437-45. PubMed ID: 16086683
[TBL] [Abstract][Full Text] [Related]
3. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis.
Li J; Gran B; Zhang GX; Rostami A; Kamoun M
J Neurol Sci; 2005 May; 232(1-2):3-9. PubMed ID: 15850576
[TBL] [Abstract][Full Text] [Related]
4. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis.
Suter T; Malipiero U; Otten L; Ludewig B; Muelethaler-Mottet A; Mach B; Reith W; Fontana A
Eur J Immunol; 2000 Mar; 30(3):794-802. PubMed ID: 10741394
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3/MAC-2 in experimental allergic encephalomyelitis.
Reichert F; Rotshenker S
Exp Neurol; 1999 Dec; 160(2):508-14. PubMed ID: 10619568
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains.
Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Arima K
Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401
[TBL] [Abstract][Full Text] [Related]
8. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
9. Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis.
Desplat-Jégo S; Creidy R; Varriale S; Allaire N; Luo Y; Bernard D; Hahm K; Burkly L; Boucraut J
Clin Immunol; 2005 Oct; 117(1):15-23. PubMed ID: 16027043
[TBL] [Abstract][Full Text] [Related]
10. The TREM-1/DAP12 pathway.
Tessarz AS; Cerwenka A
Immunol Lett; 2008 Mar; 116(2):111-6. PubMed ID: 18192027
[TBL] [Abstract][Full Text] [Related]
11. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses.
Colonna M; Facchetti F
J Infect Dis; 2003 Jun; 187 Suppl 2():S397-401. PubMed ID: 12792857
[TBL] [Abstract][Full Text] [Related]
12. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
Carter SL; Müller M; Manders PM; Campbell IL
Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
[TBL] [Abstract][Full Text] [Related]
13. Characterization of bovine cDNA encoding triggering receptor expressed on myeloid cells 1 (TREM-1).
Ramanathan B; Minton JE; Ross CR; Blecha F
Vet Immunol Immunopathol; 2004 Nov; 102(1-2):85-9. PubMed ID: 15451618
[TBL] [Abstract][Full Text] [Related]
14. Impaired differentiation of osteoclasts in TREM-2-deficient individuals.
Cella M; Buonsanti C; Strader C; Kondo T; Salmaggi A; Colonna M
J Exp Med; 2003 Aug; 198(4):645-51. PubMed ID: 12913093
[TBL] [Abstract][Full Text] [Related]
15. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
[TBL] [Abstract][Full Text] [Related]
16. TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.
Schenk M; Bouchon A; Seibold F; Mueller C
J Clin Invest; 2007 Oct; 117(10):3097-106. PubMed ID: 17853946
[TBL] [Abstract][Full Text] [Related]
17. IL-12 driven upregulation of P-selectin ligand on myelin-specific T cells is a critical step in an animal model of autoimmune demyelination.
Deshpande P; King IL; Segal BM
J Neuroimmunol; 2006 Apr; 173(1-2):35-44. PubMed ID: 16413063
[TBL] [Abstract][Full Text] [Related]
18. Early influx of macrophages determines susceptibility to experimental allergic encephalomyelitis in Dark Agouti (DA) rats.
Mensah-Brown EP; Shahin A; Al Shamisi M; Lukic ML
J Neuroimmunol; 2011 Mar; 232(1-2):68-74. PubMed ID: 21109309
[TBL] [Abstract][Full Text] [Related]
19. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
Prinz M; Schmidt H; Mildner A; Knobeloch KP; Hanisch UK; Raasch J; Merkler D; Detje C; Gutcher I; Mages J; Lang R; Martin R; Gold R; Becher B; Brück W; Kalinke U
Immunity; 2008 May; 28(5):675-86. PubMed ID: 18424188
[TBL] [Abstract][Full Text] [Related]
20. Induction of glial L-CCR mRNA expression in spinal cord and brain in experimental autoimmune encephalomyelitis.
Brouwer N; Zuurman MW; Wei T; Ransohoff RM; Boddeke HW; Biber K
Glia; 2004 Apr; 46(1):84-94. PubMed ID: 14999816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
